July 2022
Sonic Healthcare USA Announces Testing Availability for Monkeypox
Monday 18 July 2022
This week, Sonic Healthcare USA (Sonic) began testing for Monkeypox (MPXV), using the Centers for Disease Control and Prevention (CDC) Non-variola Orthopoxvirus, high complexity NAAT (RT-PCR) molecular assay...
Sonic Healthcare USA authorized by HHS to perform testing for the Monkeypox Virus
Tuesday 05 July 2022
Sonic Healthcare USA (Sonic) was selected as one of five commercial laboratories authorized by the US Department of Health and Human Services (HHS)...
December 2021
SARS-CoV-2 Omicron Variant of Concern
Wednesday 22 December 2021
SARS-CoV-2 Omicron Variant of Concern
July 2021
Sonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI (dostarlimab-gxly) Therapy in Endometrial Cancer
Sonic Healthcare USA Anatomic Pathology Division
Friday 02 July 2021
Sonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI (dostarlimab-gxly) Therapy in Endometrial Cancer
April 2021
Sonic Healthcare USA is announced as a Laboratory Testing Partner for National K-12 School Testing Program
Sonic Healthcare USA Anatomic Pathology Division
Monday 19 April 2021
Sonic Healthcare USA is announced as a Laboratory Testing Partner for National K-12 School Testing Program
October 2020
Sonic Healthcare USA Enhances Test Offerings with the Launch of Multiplex Assay for COVID-19 and Flu
Wednesday 07 October 2020
Sonic Healthcare USA has launched a multiplex RT-PCR assay that combines testing for SARS-CoV-2 (COVID-19) and Influenza A/B with a single specimen collection.
September 2020
Today, Sonic Healthcare USA (Sonic) was awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics Advanced Technology Platforms (RADx-ATP) initiative.
July 2020
New Study Validates Cytology Smears as an Alternative Sample Type for ThyroSeq Testing
Wednesday 22 July 2020
A new validation study published today, “Thyroid Cytology Smear Slides: An Untapped Resource for ThyroSeq Testing."
Sonic Healthcare USA SARS-CoV-2 (COVID-19) Media Statement
Thursday 02 July 2020
Over the last few weeks, our network of clinical laboratories throughout the United States has seen a significant increase in demand for COVID-19 molecular testing.